Chlordiazepoxide
FDA Label NDC 61919-593
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Direct Rx for the product Chlordiazepoxide (NDC 61919-593). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description:, clinical pharmacology:, indications and usage:, contraindications:, warnings:, precautions:, adverse reactions:, drug abuse and dependence:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Clinical Pharmacology:
Indications And Usage:
Contraindications:
Warnings:
Precautions:
Adverse Reactions:
Drug Abuse And Dependence:
Overdosage:
Dosage And Administration:
Storage And Handling
* Please review the disclaimer below.
